Accelmed’s most common sector for investment is software (100%). The Firm’s most common investment types include secondary buyout (100%). In total, Accelmed has invested in 1 US state.
Join Mergr to view Accelmed’s full profile and discover more small private equity firms just like it.
Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues greater than $30 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in New York City.
Join Mergr to view the latest updates and news from Accelmed.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.